{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:53:36Z","timestamp":1792824816918,"version":"4.5.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Mhealth Uhealth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the management of gestational diabetes mellitus (GDM), the usual medical treatment requires frequent visits for glucose monitoring and insulin dose adjustment, and this imposes significant physical, psychological, and economic burdens on pregnant women. As mobile health platforms become increasingly integrated into diabetes care, telemedicine may help alleviate these burdens; however, evidence evaluating its effectiveness as a replacement for routine in-person GDM care remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate the impact of telemedicine on the quality of life and costs for patients with GDM requiring insulin therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, 2-arm, randomized, open-label, parallel-group study included patients with GDM who started insulin injection therapy. Participants were randomized to either the telemedicine or standard face-to-face care groups for 10 (SD 2) weeks. The telemedicine intervention used a smartphone-linked platform that enabled the automatic transfer of glucose data from connected glucose meters and facilitated real-time video consultations. Primary end points included costs and patient satisfaction. Costs were assessed using claims data, transportation calculations, and wage-based productivity losses, while patient satisfaction was evaluated through changes in the Problem Areas in Diabetes Survey and Diabetes Therapy-Related Quality of Life questionnaire scores. Secondary outcomes included glycemic control and perinatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 38 participants were included, with 18 assigned to the telemedicine group and 20 to the standard care group. Total costs (32,712, 95% CI 15,412\u201050,013 vs 59,202, 95% CI 42,603\u201075,800 Japanese yen; $284, 95% CI 134\u2010435 vs $515, 95% CI 370\u2010659, purchasing power parity [PPP]\u2013adjusted;\n                      <jats:italic>P<\/jats:italic>\n                      =.01), direct non\u2013health care costs (922, 95% CI \u2212240 to 2084 vs 2561, 95% CI 1447\u20103676 yen; $8, 95% CI \u22122 to 18 vs $22, 95% CI 13 to 32 PPP-adjusted;\n                      <jats:italic>P<\/jats:italic>\n                      =.02), and indirect costs (8981, 95% CI \u22127119 to 25,082 vs 32,832, 95% CI 17,384\u201048,279 yen; $78, 95% CI \u221262 to 218 vs $285, 95% CI 151\u2010420 PPP-adjusted;\n                      <jats:italic>P<\/jats:italic>\n                      =.01) reduced significantly in the telemedicine group compared with the standard care group. The improvements in the Problem Areas in Diabetes Survey (\u22127.6, 95% CI \u221213.7 to \u22121.4;\n                      <jats:italic>P<\/jats:italic>\n                      =.02) and Diabetes Therapy\u2013Related Quality of Life domain 1 (10.5, 95% CI 0.9-20.1;\n                      <jats:italic>P<\/jats:italic>\n                      =.03) scores from the baseline were significantly greater in the telemedicine group than that in the standard care group. Nonetheless, glycemic control and frequency of perinatal complications were comparable between the 2 groups. Consultation time was similar across groups, suggesting no added workload for clinicians.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this randomized trial, mobile health\u2013enabled telemedicine safely replaced routine in-person visits for patients with GDM requiring insulin therapy. Telemedicine significantly reduced psychological and economic burdens without compromising glycemic or perinatal outcomes, demonstrating its value as a patient-centered and cost-efficient model of care. These findings support the broader implementation of mobile-based telemedicine approaches in GDM management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/72242","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:50:07Z","timestamp":1775605807000},"page":"e72242-e72242","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7253-6451","authenticated-orcid":false,"given":"Kazuki","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7629-3505","authenticated-orcid":false,"given":"Yuya","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-128X","authenticated-orcid":false,"given":"Shu","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-5126","authenticated-orcid":false,"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-4957","authenticated-orcid":false,"given":"Rei","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-7755","authenticated-orcid":false,"given":"Mariko","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6621-4237","authenticated-orcid":false,"given":"Takeshi","family":"Arimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-9591","authenticated-orcid":false,"given":"Yoshifumi","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-4271","authenticated-orcid":false,"given":"Mamoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-4919","authenticated-orcid":false,"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4923-1550","authenticated-orcid":false,"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","journal-title":"Nat Rev Dis Primers"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4694","article-title":"Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis","volume":"354","author":"Farrar","journal-title":"BMJ"},{"issue":"10","key":"R3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2018.11628","article-title":"Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity","volume":"320","author":"Lowe","journal-title":"JAMA"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7058082","article-title":"Quality of life in women with gestational diabetes mellitus: a systematic review","volume":"2017","author":"Marchetti","journal-title":"J Diabetes Res"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-1689-1","article-title":"The short-term economic burden of gestational diabetes mellitus in Italy","volume":"18","author":"Meregaglia","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1357633X0501100102","article-title":"Introduction to the practice of telemedicine","volume":"11","author":"Craig","journal-title":"J Telemed Telecare"},{"issue":"3","key":"R7","doi-asserted-by":"publisher","DOI":"10.2196\/16791","article-title":"Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses","volume":"22","author":"Timpel","journal-title":"J Med Internet Res"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/jim-2016-000199","article-title":"Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis","volume":"65","author":"Lin","journal-title":"J Investig Med"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","DOI":"10.2196\/23244","article-title":"Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review","volume":"23","author":"Eberle","journal-title":"J Med Internet Res"},{"issue":"11","key":"R10","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6556","article-title":"Telemedicine technologies for diabetes in pregnancy: a systematic review and meta-analysis","volume":"18","author":"Ming","journal-title":"J Med Internet Res"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-02892-1","article-title":"Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: an updated meta-analysis of 32 randomized controlled trials with trial sequential analysis","volume":"20","author":"Xie","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.9512","article-title":"Comparing the efficacy of a mobile phone-based blood glucose management system with standard clinic care in women with gestational diabetes: randomized controlled trial","volume":"6","author":"Mackillop","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/dia.2019.0259","article-title":"Demonstrated cost-effectiveness of a telehomecare program for gestational diabetes mellitus management","volume":"22","author":"Lemelin","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22504","article-title":"Efficacy and safety of a telemedicine system in subjects with gestational diabetes mellitus (TELEGLAM): study protocol for a randomized controlled trial","volume":"9","author":"Aoyama","journal-title":"Heliyon"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1507\/endocrj.EJ21-0118","article-title":"Predictors of later insulin therapy for gestational diabetes diagnosed in early pregnancy","volume":"68","author":"Tamagawa","journal-title":"Endocr J"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1507\/endocrj.EJ22-0521","article-title":"Risk factors of neonatal hypoglycemia in neonates born to mothers with gestational diabetes","volume":"70","author":"Arimitsu","journal-title":"Endocr J"},{"issue":"3","key":"R17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel","journal-title":"Diabetes Care"},{"key":"R18","unstructured":"Kirch W . Encyclopedia of Public Health. Springer; 2008. ISBN: 978-1-4020-5613-0"},{"issue":"5","key":"R19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2337\/diacare.20.5.760","article-title":"The Problem Areas in Diabetes Scale. An evaluation of its clinical utility","volume":"20","author":"Welch","journal-title":"Diabetes Care"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13340-023-00661-x","article-title":"The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes","volume":"15","author":"Hayashino","journal-title":"Diabetol Int"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3111\/13696998.2012.665111","article-title":"Development and psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire","volume":"15","author":"Ishii","journal-title":"J Med Econ"},{"issue":"3","key":"R22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.diabres.2012.04.005","article-title":"The association between Problem Areas in Diabetes Scale scores and glycemic control is modified by types of diabetes therapy: diabetes distress and care registry in Tenri (DDCRT 2)","volume":"97","author":"Hayashino","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"R23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/dme.12887","article-title":"How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS)","volume":"33","author":"Schmitt","journal-title":"Diabet Med"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","DOI":"10.1097\/jnr.0000000000000456","article-title":"Effectiveness of a nurse-led web-based health management in preventing women with gestational diabetes from developing metabolic syndrome","volume":"29","author":"Su","journal-title":"J Nurs Res"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40618-018-0975-0","article-title":"Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus","volume":"42","author":"Guo","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"R26","doi-asserted-by":"publisher","DOI":"10.2196\/22881","article-title":"Comparing the efficacies of telemedicine and standard prenatal care on blood glucose control in women with gestational diabetes mellitus: randomized controlled trial","volume":"9","author":"Tian","journal-title":"JMIR Mhealth Uhealth"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.05.049","article-title":"Using technology to support care in gestational diabetes mellitus: quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM)","volume":"142","author":"Rasekaba","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3961\/jpmph.16.043","article-title":"A systematic review of the economic evaluation of telemedicine in Japan","volume":"49","author":"Akiyama","journal-title":"J Prev Med Public Health"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/386941","article-title":"The outcomes of gestational diabetes mellitus after a telecare approach are not inferior to traditional outpatient clinic visits","volume":"2010","author":"P\u00e9rez-Ferre","journal-title":"Int J Endocrinol"},{"issue":"8","key":"R30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00592-023-02099-8","article-title":"Effectiveness of a comprehensive telemedicine intervention replacing standard care in gestational diabetes: a randomized controlled trial","volume":"60","author":"Munda","journal-title":"Acta Diabetol"},{"issue":"3","key":"R31","doi-asserted-by":"publisher","DOI":"10.2196\/24284","article-title":"Effects of telemetric interventions on maternal and fetal or neonatal outcomes in gestational diabetes: systematic meta-review","volume":"6","author":"Eberle","journal-title":"JMIR Diabetes"}],"container-title":["JMIR mHealth and uHealth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mhealth.jmir.org\/2026\/1\/e72242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:02:30Z","timestamp":1782842550000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhealth.jmir.org\/2026\/1\/e72242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/72242","relation":{},"ISSN":["2291-5222"],"issn-type":[{"value":"2291-5222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"v14i1e72242"}}